Cargando…

Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

OBJECTIVES: The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) was designed to evaluate the conventional NSAID naproxen sodium and the selective COX-2 inhibitor celecoxib for primary prevention of Alzheimer's dementia (AD). On 17 December 2004, after the Adenoma Prevention...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851724/ https://www.ncbi.nlm.nih.gov/pubmed/17111043 http://dx.doi.org/10.1371/journal.pctr.0010033

Ejemplares similares

Role of APOE and Age at Enrollment in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
por: Drye, Lea T., et al.
Publicado: (2012)

Cerebrovascular events after cardiovascular surgery: diagnosis, management and prevention strategies
por: Ferrante, Maria Sabrina, et al.
Publicado: (2023)

Electrocardiographic abnormalities in acute cerebrovascular events in patients with/without cardiovascular disease
por: Togha, Mansoureh, et al.
Publicado: (2013)

Controlling Hypertension After Severe Cerebrovascular Event (CHASE): study protocol for a randomized controlled trial
por: Yuan, Fang, et al.
Publicado: (2018)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease
por: Higgins, Peter, et al.
Publicado: (2009)

The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial
por: Lao, Miaochan, et al.
Publicado: (2022)

Examining anti-inflammatory therapies in the prevention of cardiovascular events: protocol for a systematic review and network meta-analysis of randomised controlled trials
por: Boczar, Kevin Emery, et al.
Publicado: (2022)

Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis
por: Santos, Cláudia Y., et al.
Publicado: (2017)

Cerebrovascular Events in Pediatric Inflammatory Bowel Disease: A Review of Published Cases
por: Rohani, Pejman, et al.
Publicado: (2022)

Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
por: Gu, Hong-Qiu, et al.
Publicado: (2020)

Efficacy and Safety of Bempedoic Acid to Prevent Cardiovascular Events in Individuals at Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized-Control Trials
por: Krishna Mohan, Gautham Varun, et al.
Publicado: (2023)

Hypertension, BMI, and cardiovascular and cerebrovascular diseases
por: Qiao, Wenjing, et al.
Publicado: (2021)

Natural Antioxidant in Cardiovascular and Cerebrovascular Diseases
por: Jung, Yi-Sook
Publicado: (2022)

Efficacy and safety of inclisiran in stroke or cerebrovascular disease prevention: a systematic review and meta-analysis of randomized controlled trials
por: Luo, Min, et al.
Publicado: (2023)

Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men
por: Yeap, Bu B
Publicado: (2018)

Predictive and preventive strategies to advance the treatments of cardiovascular and cerebrovascular diseases: the Ukrainian context
por: Lushchyk, Ulyana B, et al.
Publicado: (2012)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan, Jing, et al.
Publicado: (2013)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Cerebrovascular insulin receptors are defective in Alzheimer’s disease
por: Leclerc, Manon, et al.
Publicado: (2022)

Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
por: Thanigaimani, Shivshankar, et al.
Publicado: (2021)

Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
por: Laing, Krystal K, et al.
Publicado: (2020)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Anti‐Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial
por: Ajala, Oluremi N., et al.
Publicado: (2020)

Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)
por: Wang, Penglian, et al.
Publicado: (2012)

Treatment of Rivaroxaban versus Aspirin for Non-disabling Cerebrovascular Events (TRACE): study protocol for a randomized controlled trial
por: Yang, Fang, et al.
Publicado: (2015)

Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
por: Delbaere, Quentin, et al.
Publicado: (2023)

Representation and reporting of kidney disease in cerebrovascular disease: A systematic review of randomized controlled trials
por: Konstantinidis, Ioannis, et al.
Publicado: (2017)

Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis
por: de Vries, Folgerdiena M., et al.
Publicado: (2014)

Automatic Prediction of Cardiovascular and Cerebrovascular Events Using Heart Rate Variability Analysis
por: Melillo, Paolo, et al.
Publicado: (2015)

Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19
por: Schwarz, Viktoria, et al.
Publicado: (2020)

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
por: Radin, Massimo, et al.
Publicado: (2021)

Application of fucoidan as treatment for cardiovascular and cerebrovascular diseases
por: Wang, Ke, et al.
Publicado: (2022)

Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
por: Klohs, Jan, et al.
Publicado: (2014)

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2018)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
por: Asby, Daniel, et al.
Publicado: (2021)

Alzheimer’s disease, cerebrovascular disease and dementia: lump, split or integrate?
por: Biessels, Geert Jan
Publicado: (2022)

Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
por: Bredemeier, Markus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gorrgmodg7b4ms5cjm0njttc8q